NASDAQ:CYRN Cyren Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cyren Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.98 -0.05 (-4.86 %) (As of 09/21/2020 12:00 AM ET) Add Compare Share Today's Range$0.92Now: $0.98▼$1.0250-Day Range$0.96MA: $1.19▼$1.7252-Week Range$0.31Now: $0.98▼$1.97Volume93,675 shsAverage Volume88,770 shsMarket Capitalization$59.18 millionP/E RatioN/ADividend YieldN/ABeta0.81 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media CYREN Ltd., together with its subsidiaries, provides information security solutions for protecting Web, email, and mobile transactions worldwide. The company operates Cyren Cloud Security, a SaaS security platform, which provides Internet security services, including Web Security that provides the enforcement of Web policy and state-of-the-art threat protection for business users; DNS Security, which allows businesses to protect employees at headquarters, visitors in remote offices, customers at retail stores, or students on a campus; Email Security, a cloud-based secure email gateway; and Cloud Sandboxing that protects businesses against breaches and data loss from threats. It also operates Cyren Threat Intelligence Services, a platform that offers cloud-based cyber threat detection APIs and SDKs to technology and security vendors. The company's threat intelligence services comprise embedded email and Web security services; Endpoint Security, which detects malware on various endpoints, including mobile devices and embedded operating system devices; and advanced threat protection services that comprise tools for combating mobile malware, ransomware, and other Web-borne threats. CYREN Ltd. sells its products through direct and indirect channels, including value added resellers and managed service providers to enterprise customers and original equipment manufacturers. The company was formerly known as Commtouch Software Ltd. and changed its name to CYREN Ltd. in January 2014. CYREN Ltd. was founded in 1991 and is headquartered in McLean, Virginia. CYREN Ltd. is a subsidiary of WP XII Investments B.V.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Cyren. Previous Next 2.6 Community Rank Outperform VotesCyren has received 206 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCyren has received 196 “underperform” votes. (Add your “underperform” vote.)Community SentimentCyren has received 51.24% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Cyren and other stocks. Vote “Outperform” if you believe CYRN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CYRN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCyren does not currently pay a dividend.Dividend GrowthCyren does not have a long track record of dividend growth. Previous Next 2.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cyren insiders have not sold or bought any company stock.Percentage Held by Insiders57.74% of the stock of Cyren is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions59.22% of the stock of Cyren is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cyren is -3.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cyren is -3.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCyren has a P/B Ratio of 2.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.92 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:CYRN Previous Symbol CUSIPN/A CIK1084577 Webwww.cyren.com Phone972-9863-6888Debt Debt-to-Equity Ratio1.04 Current Ratio1.18 Quick Ratio1.18Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$38.39 million Price / Sales1.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.42 per share Price / Book2.33Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-18,020,000.00 Net Margins-42.88% Return on Equity-75.97% Return on Assets-25.13%Miscellaneous Employees248 Outstanding Shares60,414,000Market Cap$59.18 million Next Earnings Date11/11/2020 (Estimated) OptionableNot Optionable $0.98 -0.05 (-4.86 %) (As of 09/21/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CYRN News and Ratings via Email Sign-up to receive the latest news and ratings for CYRN and its competitors with MarketBeat's FREE daily newsletter. Cyren (NASDAQ:CYRN) Frequently Asked Questions How has Cyren's stock price been impacted by Coronavirus? Cyren's stock was trading at $0.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CYRN stock has increased by 3.1% and is now trading at $0.9795. View which stocks have been most impacted by COVID-19. When is Cyren's next earnings date? Cyren is scheduled to release its next quarterly earnings announcement on Wednesday, November 11th 2020. View our earnings forecast for Cyren. How were Cyren's earnings last quarter? Cyren Ltd (NASDAQ:CYRN) announced its earnings results on Wednesday, August, 12th. The technology company reported ($0.08) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.05) by $0.03. The technology company earned $9.18 million during the quarter. Cyren had a negative net margin of 42.88% and a negative return on equity of 75.97%. View Cyren's earnings history. Are investors shorting Cyren? Cyren saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 8,200 shares, a decline of 86.0% from the August 15th total of 58,700 shares. Based on an average daily trading volume, of 164,900 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold. View Cyren's Short Interest. Who are some of Cyren's key competitors? Some companies that are related to Cyren include Xunlei (XNET), Red Violet (RDVT), MiX Telematics (MIXT), GlobalSCAPE (GSB), Smith Micro Software (SMSI), DIRTT Environmental (DRTT), Audioeye (AEYE), Coro Global (CGLO), SharpSpring (SHSP), Intellicheck (IDN), MTBC (MTBC), Inspired Entertainment (INSE), Datasea (DTSS), Qumu (QUMU) and Great Elm Capital Group (GEC). View all competitors. What other stocks do shareholders of Cyren own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Onconova Therapeutics (ONTX), Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Opko Health (OPK), Vaxart (VXRT), Biocept (BIOC), Heat Biologics (HTBX), Ibio (IBIO), MEI Pharma (MEIP) and VBI Vaccines (VBIV). Who are Cyren's key executives? Cyren's management team includes the following people: Mr. Lior Samuelson, Chairman & CEO (Age 70)Mr. J. Michael Myshrall, Chief Financial Officer (Age 50)Mr. Lior Kohavi, Chief Technology Officer (Age 48)Mr. Eric Avi Spindel, VP, Gen. Counsel & Corp. Sec. (Age 42)Mr. Dominick David DiPietro, VP of Sales - North America (Age 54) What is Cyren's stock symbol? Cyren trades on the NASDAQ under the ticker symbol "CYRN." Who are Cyren's major shareholders? Cyren's stock is owned by a variety of institutional and retail investors. Top institutional investors include Nantahala Capital Management LLC (1.77%), Belpointe Asset Management LLC (0.95%) and Meitav Dash Investments Ltd. (0.74%). Company insiders that own Cyren stock include Atif Ahmed, Joseph Michael Myshrall, Lior Samuelson and Sigurdur Arnar Stefnisson. View institutional ownership trends for Cyren. Which major investors are selling Cyren stock? CYRN stock was sold by a variety of institutional investors in the last quarter, including Meitav Dash Investments Ltd.. Company insiders that have sold Cyren company stock in the last year include Atif Ahmed, and Sigurdur Arnar Stefnisson. View insider buying and selling activity for Cyren. Which major investors are buying Cyren stock? CYRN stock was acquired by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, and Belpointe Asset Management LLC. View insider buying and selling activity for Cyren. How do I buy shares of Cyren? Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Cyren's stock price today? One share of CYRN stock can currently be purchased for approximately $0.98. How big of a company is Cyren? Cyren has a market capitalization of $59.18 million and generates $38.39 million in revenue each year. Cyren employs 248 workers across the globe. What is Cyren's official website? The official website for Cyren is www.cyren.com. How can I contact Cyren? Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected] This page was last updated on 9/22/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
